drugset / Trial / NCT00018902

Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)

NCT00018902

RandomizedFactorialQuadruple-blindTreatment

Summary

The purpose of the study is to determine how best to treat adolescents with depression that is "resistant" to the first SSRI antidepressant they have tried. Participants receive one of three other antidepressant medications, either alone or in combination with cognitive behavioral therapy.

Timeline

Start
2001-01
Primary completion
2007-03
Completion
2007-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Citalopram Small molecule
Subject Fluoxetine Small molecule
Subject Venlafaxine Small molecule

Indications